Phrontline Biopharma Funding: $68M Raised, Pre-A+ (2025)

Phrontline Biopharma funding overview

Phrontline Biopharma is based in Shanghai, China. Phrontline Biopharma has raised $68M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Pre-A+ announced in November 2025. The round record for Phrontline Biopharma runs through 2025; nothing later has been disclosed. Investors on record include Lapam Investment, Samsung Venture Investment Corporation (SVIC), Guofang Innovation, Hankang Venture Capital, Songqing Capital, Jifeng Ventures and 4 others. 10 distinct backers are named across the disclosed rounds.

Phrontline Biopharma at a glance

Total raised: $68M
Latest round: Pre-A+
Latest round date: November 2025
Headquarters: Shanghai, China
Notable investors: Lapam Investment, Samsung Venture Investment Corporation (SVIC), Guofang Innovation, Hankang Venture Capital, Songqing Capital, Jifeng Ventures, Sino Biopharmaceutical Limited, Decheng Capital

Frequently asked about Phrontline Biopharma funding

How much has Phrontline Biopharma raised?: Phrontline Biopharma has raised $68M in total disclosed funding across the rounds on record.
Who has invested in Phrontline Biopharma?: Lapam Investment, Samsung Venture Investment Corporation (SVIC), Guofang Innovation, Hankang Venture Capital, Songqing Capital, Jifeng Ventures are named among the investors backing Phrontline Biopharma.
What was the latest Phrontline Biopharma funding round?: The most recent disclosed round is a Pre-A+, announced in November 2025.
Where is Phrontline Biopharma based?: Phrontline Biopharma is based in Shanghai, China.
When did Phrontline Biopharma last raise?: The last disclosed Phrontline Biopharma round closed in November 2025 at Pre-A+.

Round data for Phrontline Biopharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.

Phrontline Biopharma Funding: $68M Raised, Pre-A+ (2025)

Phrontline Biopharma funding overview

Phrontline Biopharma at a glance

Frequently asked about Phrontline Biopharma funding

Companies related to Phrontline Biopharma (19)

Browse related funding lists (4)